Global Proteomics Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 23.2 Billion in 2017 and is projected to grow at a CAGR of 14.1% over the forecast period. Proteomes are a set of proteins which are produced in a system, organism, or any biological entity. Study of proteomes is known as proteomics. It is used in various applications, like investigation of protein expression, transcriptional & post transcriptional studies, metabolic pathways, protein interaction in diseases, etc.
The factors such as increasing research & development activities in the healthcare industry, rising demand for personalized medicines, rising number of approvals of personalized medicines and increasing activities of drug discovery are expected to propel the growth of the market. According to Foley & Lardner LLP, Food and Drug Administration (FDA) approved 16 new personalized medicine therapies in 2017. However, the high cost of devices and lack of skilled researchers can hamper the market growth over the forecast period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6930
Regional Analysis:
Geographically, the Americas is expected to dominate the global market owing to the easy availability of funds from various organizations and rising interest in personalized medicines. According to the Personalized Medicine Coalition, number of available personalized medicines increased to 113 in 2014 from 13 in 2006. Europe is expected to hold the second largest position in the global market owing to the rising cancer research activities and high funding from the government. Asia-Pacific is expected to be the fastest growing market owing to the high prevalence of cancer and rising healthcare expenditure. Moreover, the Middle East and Africa region is expected to account for the least proteomics market share in the global market.
Segmentation (largest & fastest):
The global proteomics market has been segmented into equipment, services and application.The market, on the basis of equipment, has been segmented into chromatography, mass spectroscopy, protein microarray, X-ray crystallography, protein fractionation and others.The global market, on the basis of services, has been segmented into laboratory services and data analysis & services.
The global proteomics market, by application, has been segmented into drug discovery, clinical diagnosis and others. The clinical diagnosis segment is expected to hold the largest market share owing to the increased understanding of the relevance of investigating and understanding patterns of protein expression for diseases & drug development. The drug discovery segment is anticipated to grow at the fastest CAGR owing to continuous search for alternative & efficient methods to deliver enhanced drugs and increased R&D investments by pharmaceutical & biotechnology companies.
Key Players:
Some of the prominent players in the global proteomics market are GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and Others.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/proteomics-market-6930
No comments:
Post a Comment